1998
DOI: 10.1016/s0040-4039(97)10532-9
|View full text |Cite
|
Sign up to set email alerts
|

Synthetic studies on the immunosuppressive agent FK-506: Enantioselective synthesis of a C22C34 fragment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
1
0

Year Published

1998
1998
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 15 publications
1
1
0
Order By: Relevance
“…In all of the above examples the enolate was prepared by “soft enolization” (TiCl 4 , i -Pr 2 EtN) . Related examples where transmetalation of a Li enolate was used to prepare the Ti(IV) enolate involve reactions with enantiopure aldehydes, and the corresponding 1,3- syn -1,1′- syn - 11 adducts were formed with varying selectivity depending on whether the reaction was “matched” (dr 20:1) or “mismatched” (dr 1–9:1). , The diastereoselectivities in Table are consistent with the above literature examples. In contrast to the other enolates studied (Tables –), consistently high selectivity (dr ≥9:1) was observed with the Ti(IV) enolates regardless of the relative configuration or protecting group in the starting ketone.…”
Section: Resultssupporting
confidence: 83%
“…In all of the above examples the enolate was prepared by “soft enolization” (TiCl 4 , i -Pr 2 EtN) . Related examples where transmetalation of a Li enolate was used to prepare the Ti(IV) enolate involve reactions with enantiopure aldehydes, and the corresponding 1,3- syn -1,1′- syn - 11 adducts were formed with varying selectivity depending on whether the reaction was “matched” (dr 20:1) or “mismatched” (dr 1–9:1). , The diastereoselectivities in Table are consistent with the above literature examples. In contrast to the other enolates studied (Tables –), consistently high selectivity (dr ≥9:1) was observed with the Ti(IV) enolates regardless of the relative configuration or protecting group in the starting ketone.…”
Section: Resultssupporting
confidence: 83%
“…For example, ( S )-CHCM has been applied to the synthesis of FK-506, the aglycone of the antitumor drug (+)-phyllanthocin, the sex pheromone components periplanone A and B, the toxin pumiliotoxin C, the repellent SS220, the unnatural amino acid β-homoglutamic acid, carbacyclic-(1 → 3)-glucan mimetics, and the inhibitor of coagulant factor Xa (fXa), which is commercially known as Edoxaban and used for the treatment of cancer-associated venous thromboembolism due to its superior oral adsorption and lower bleeding risk compared to those of other anticoagulants (Scheme A) . ( R )-CHCM has also been applied to the synthesis of the immunosuppressant FK-506 (Tacrulimus), the anti-influenza drug oseltamivir phosphate (Tamiflu), the natural products leustroducsin B and phyllanthocin, potential antibacterials, and E-selectin antagonists …”
mentioning
confidence: 99%